Takeda UK ADHD Innovation Challenge

Accelerating personalised ADHD healthcare

Apply to Win a Chance to Accelerate Your Innovation with Takeda UK!

Takeda UK, in partnership with The ADHD Foundation and Eastern AHSN (Academic Health Science Network), is launching a call for applications to our newest digital challenge to benefit patients who have Attention Deficit Hyperactivity Disorder (ADHD). What can Takeda offer?

A dedicated point of contact at Takeda UK
  • Finalists will receive a direct response about collaboration potential at the end of the Innovation Challenge
Takeda’s resources & expertise
  • Partnership with Takeda UK including potential investment for the winning team(s) for proof-of-concept development in the UK
  • Access to mentoring and coaching from Takeda experts from cross functional teams (including medical capabilities, commercial and marketing) to help bring your innovation to fruition
  • Benefit from Takeda’s international network of partners and suppliers
Takeda welcomes submissions from UK and international applicants. Please note that any pilot will be conducted in collaboration with Takeda UK and rolled out within the United Kingdom.

Why an ADHD Innovation Challenge?

Takeda is committed to bringing better health and a brighter future to people worldwide through leading innovation in medicine. As a patient-driven, science-first R&D organization, Takeda combines cutting-edge technologies with a focus on core therapeutic areas: Oncology, Rare Diseases, Neuroscience, Gastroenterology, Plasma-Derived Therapies and Vaccines.

Takeda is accelerating the use of digital and data to speed delivery of life-saving medicines, while also easing the burden of diagnosis and treatment for patients, their families and healthcare providers. Innovation across the entire healthcare ecosystem holds the key to fully unlocking the power of digital and data for improved patient outcomes.

Takeda is proud to be patient-centric and partner-focused. 

To make a bigger impact on peoples’ lives, Takeda is opening its doors to new partnerships that will accelerate the future of personalised healthcare.

Enter Takeda UK’s ADHD Innovation Challenge: Applications are invited from companies, institutions or organisations. We're looking for bold ideas and solutions to increase ADHD recognition and diagnosis and/or improve patient education, support and management in ADHD within the UK.

What Are We Looking For?
Are you building an innovation solution that could accelerate the future of personalised ADHD healthcare in the UK?
Does your solution bring innovation and disruption to one of the following fields?
Increasing ADHD recognition/diagnosis

ADHD is under recognised/under diagnosed across the UK in all age groups. Solutions could include building disease awareness, digital tools to support HCP screening and assessment or facilitating expert consultation for clinical management, and/or personalised risk prediction.

Patient educational resources, support & monitoring

There is a lack of patient accessible support and monitoring, either face to face or online. This has been further disrupted with COVID 19, meaning that support/education programmes have either been cancelled or delayed. There is also a variation in services provided across the UK, with increased waiting lists to commence treatment plans.

Takeda UK is looking for innovative ideas and technologies in either of the above fields that utilise Artificial Intelligence (AI), Machine Learning (ML), Natural Language Processing (NLP), data capture and access, digital biomarkers, clinical decision support, virtual peer-peer consults, awareness building, Artificial Reality(AR)/Virtual Reality (VR), gamification, sensing and wearables, and beyond.
UK ADHD Innovation Challenge Q&A Webinars

Sign up for one of our UK ADHD Innovation Challenge Q&A Webinars for an opportunity to ask questions and learn more. Click on the date you would like to attend to register.

September 26th 4pm-5pm BST

September 27th 11am-12pm BST